Oct 25, 2021
In this episode, Benjamin Derman, MD, discusses
his work on addressing disparities in hematology and oncology, the
impact the pandemic has had on these issues and much more.
- Welcome to another exciting episode of Oncology Overdrive
- About Derman :17
- The interview 1:33
- The field you’re in is super, super specialized … can you tell
me a little bit about your journey into how you went into medicine,
how you went into this field and then how you started working on
some disparities work as well? 1:46
- Do you feel like you’re now in a place where you have to
explain things to people where it sounds like science fiction, but
it actually is really a powerful way to treat a lot of cancers?
- How did you start working in the disparities space and why do
you think it’s so important that we really focus on this as a topic
that we address within oncology and hematology?
- How do we change how we are treating patients from a system
level? A national level? An institutional level?
- Do you think, in the last year and a half, COVID has helped or
hurt this mission? 21:21
- We talk about informed decision making and patients think they
are making an informed decision, although the information they have
is from a bunk source. 27:04
- A discussion on how to guide patients, risk levels/factors and
navigating life 27:53
- What are your thoughts on testing for spike antibodies?
- The impact of telehealth and telemedicine on patients during
the pandemic 39:36
- Derman’s one pearl 40:59
- How to contact Derman 41:58
Benjamin Derman, MD, is an assistant professor
of medicine in the University of Chicago Department of Medicine’s
section of Hematology/Oncology.
We’d love to hear from you! Send your comments/questions to Dr.
Jain at email@example.com.
Follow us on Twitter @HemOncToday and @ShikhaJainMD. Derman can be reached on
Disclosures: Derman reports no relevant
financial disclosures. Jain reports she is a paid freelance writer